Deshpande Shrikalp Shrikant

@ksv.ac.in

Professor
Kadi Sarva Vishwavidhyalaya



              

https://researchid.co/shrikalp

EDUCATION

M.Pharm, MMS, PhD

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmaceutical Science, Pharmacology, Toxicology and Pharmaceutics, Drug Discovery, Pharmacology

FUTURE PROJECTS

Pharmacovigilance

Survey Online/Offline (Hybrid)


Applications Invited
Students

GCP Training

Workshop Online


Applications Invited
Students
851

Scholar Citations

13

Scholar h-index

23

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • RNA-Based Cancer Vaccines: Advancement and Challenges
    PA Shah, RA Shukla, MR Chorawala, NP Kakadia, B Prajapati, ...
    Cancer Vaccination and Challenges, 133-176 2024

  • Regulatory requirements for approval and registration procedure of biosimilar in US and European Union (EU)
    N Patel, H Prajapati, N Joshi, V Movaliya, N Kanaki, S Deshpande, ...
    International Journal Of Drug Regulatory Affairs 12 (1), 70-82 2024

  • Overview of post-approval submissions management in US, Europe and Canada
    C Patel, R Patel, N Kanaki, V Movaliya, S Deshpande, M Zaveri
    International Journal Of Drug Regulatory Affairs 12 (1), 61-69 2024

  • A Prospective Study on Evaluation of Antibiotic Usage Pattern in Hospitals
    R Patel, R Patel, K Patel, M Soni, P Rathod, S Deshpande
    Indian Journal of Pharmacy Practice 17 (1) 2024

  • Efficacy and Tolerability Evaluation of a Nutraceutical Composition Containing Vitex agnus-castus Extract (EVX40™), Pyridoxine, and Magnesium in Premenstrual Syndrome: A Real
    VP Sureja, DB Kheni, VP Dubey, J Kansagra, ZK Soni, SP Bhatt, ...
    Cureus 15 (8) 2023

  • Comparative Evaluation of Aldose Reductase Inhibition in Polycystic Ovarian Syndrome–Induced Rats
    R Patel, Z Pathak, S Deshpande, G Shah
    Reproductive Sciences 30 (2), 622-632 2023

  • A comparative evaluation of Regulatory requirements for registration of dietary supplements in Brazil, Russia, India, China and South Africa
    K Gajjar, Z Patel, V Movaliya, N Kanaki, S Deshpande, M Zaveri
    International Journal Of Drug Regulatory Affairs 11 (3), 53-61 2023

  • Similarities and differences in filing for Drug Master File in US, Canada and Europe
    U Suthar, Z Patel, V Movaliya, N Kanaki, S Deshpande, M Zaveri
    International Journal Of Drug Regulatory Affairs 11 (3), 33-38 2023

  • A CROSS-SECTIONAL STUDY CONDUCTED FOR THE ASSESSMENT OF PREMENSTRUAL SYMPTOMS AMONG THE ADOLESCENT SCHOOL GIRLS OF MEHSANA CITY
    PR PARMAR, SS DESHPANDE
    Asian J Pharm Clin Res 16 (10), 191-195 2023

  • Drugs manufacturing license allocation (DMLA): An effective tool for e-governance in fields of drugs manufacturing regulation
    Z Patel, S Deshpande, H Koshia, P Patel
    International Journal Of Drug Regulatory Affairs 11 (2), 58-63 2023

  • Recent regulatory scenario of nitrosamines impurities in regulated market US, Europe and Canada
    R Trivedi, A Trivedi, V Movaliya, K Vaghela, N Kanaki, S Deshpande, ...
    International Journal Of Drug Regulatory Affairs 11 (2), 30-36 2023

  • Good e-Governance: Xtended licensing, laboratory & legal node (XLN)-An effective tool for good regulatory practice in field of drugs and cosmetics regulation
    Z Patel, S Deshpande, V Jambukiya, H Koshia
    International Journal Of Drug Regulatory Affairs 11 (1), 43-46 2023

  • Awareness and practices about menstruation among adolescent girls: A cross-sectional study
    PR Parmar, SS Deshpande
    Current Medicine Research and Practice 12 (6), 265-269 2022

  • Efficacy of Myo-inositol on anthropometric, metabolic, and endocrine outcomes in PCOS patients: a meta-analysis of randomized controlled trial
    H Jethaliya, N Gajjar, V Patel, S Deshpande, R Patel
    Reproductive Sciences 29 (8), 2282-2298 2022

  • ASSESSMENT AND EVALUATION OF PRESCRIBING PATTERN OF ANTIMICROBIAL AGENTS IN INTENSIVE CARE UNIT OF TERTIARY CARE HOSPITAL
    T Lalwani, S Deshpande, V Patel
     2022

  • SCREENING AND ASSESSMENT OF METABOLIC SYNDROME AND ITS KNOWLEDGE IN AN URBAN POPULATION: A CROSS-SECTIONAL STUDY
    H Jethaliya, V Patel, M Patel, A Patel, C Patel, S Deshpande
     2022

  • Biosimilar Approval in Europe with Registration Pathways
    T Ankit, D Shrikalp, Z Maitreyi, P kumar Jain, K Kiran, TV Pathak
    NeuroQuantology 20 (8), 121 2022

  • Overview Of Biosimilar and General Consideration for Biosimilar Drug Development
    T Ankit, D Shrikalp, Z Maitreyi, P kumar Jain, KKTV Pathak
    NeuroQuantology 20 (8), 130 2022

  • Regulatory prospective on software as a medical device
    F Chothani, V Movaliya, K Vaghela, M Zaveri, S Deshpande, N Kanki
    International Journal Of Drug Regulatory Affairs 10 (4), 13-17 2022

  • FDA’s new pharmaceutical quality initiative: Knowledge-aided assessment & structured applications
    P Govani, K Bahekar, V Movaliya, K Vaghela, N Kanki, S Deshpande, ...
    International Journal Of Drug Regulatory Affairs 10 (4), 1-7 2022

MOST CITED SCHOLAR PUBLICATIONS

  • Antiulcer activity of Tephrosia purpurea in rats
    SS Deshpande, GB Shah, NS Parmar
    Indian journal of Pharmacology 35 (3), 168-172 2003
    Citations: 226

  • Effect of Vitex negundo L. seeds in letrozole induced polycystic ovarian syndrome
    N Kakadia, P Patel, S Deshpande, G Shah
    Journal of Traditional and Complementary Medicine 9 (4), 336-345 2019
    Citations: 66

  • Evaluation of efficacy of vitamin E and N-acetyl cysteine in gentamicin-induced nephrotoxicity in rats
    B Patel Manali, S Deshpande, G Shah
    Renal failure 33 (3), 341-347 2011
    Citations: 53

  • Evaluation of the antiasthmatic activity of leaves of Vitex negundo
    J Patel, S Shah, S Deshpande, G Shah
    Asian J Pharm Clin Res 2 (1), 81-6 2009
    Citations: 44

  • Anti-arthritic activity of cell wall content of Lactobacillus plantarum in freund’s adjuvant-induced arthritic rats: involvement of cellular inflammatory mediators and
    P Gohil, V Patel, S Deshpande, M Chorawala, G Shah
    Inflammopharmacology 26, 171-181 2018
    Citations: 33

  • Liver x receptor: a novel therapeutic target
    MB Patel, NA Oza, IS Anand, SS Deshpande, CN Patel
    Indian journal of pharmaceutical sciences 70 (2), 135 2008
    Citations: 33

  • Antiulcer activity of aqueous extract of Basella rubra in albino rats
    SS Deshpande, GB Shah, I Deshpande, NS Parmar
    Journal of Natural Remedies 3 (2), 212-214 2003
    Citations: 23

  • Amelioration of complete Freund’s adjuvant-induced arthritis by Calotropis procera latex in rats
    R Patel, S Kadri, P Gohil, S Deshpande, G Shah
    Future Journal of Pharmaceutical Sciences 7, 1-11 2021
    Citations: 18

  • Anti-nociceptive and anti-allodynic activity of aliskiren in various pain models
    RB Patel, VD Pawar, KD Prajapati, BM Sonara, SS Deshpande, GB Shah, ...
    European journal of pharmacology 708 (1-3), 80-87 2013
    Citations: 18

  • Pharmacoeconomic Evaluation Cost Minimization Analysis of Anti-Diabetic Therapy in Gujarat
    V Shah Jainam, N Patni Kalyani, S Deshpande Shrikalp
    Int J Med Res Health Sci 5 (3), 34-43 2016
    Citations: 16

  • Antieosinophilic activity of various subfractions of leaves of Vitex negundo
    JI Patel, SS Deshpande
    International Journal of Nutrition, Pharmacology, Neurological Diseases 3 (2 2013
    Citations: 15

  • Linagliptin: a novel xanthine-based dipeptidyl peptidase-4 inhibitor for treatment of type II diabetes mellitus
    S B Ghatak, D S Patel, N Shanker, A Srivastava, S S Deshpande, ...
    Current diabetes reviews 7 (5), 325-335 2011
    Citations: 14

  • Assessment of demographics, treatment strategies, and evidence-based medicine use among diabetic and non-diabetic patients with acute coronary syndrome: a cohort study
    BS Shah, SS Deshpande
    Journal of Pharmacology and Pharmacotherapeutics 5 (2), 139-144 2014
    Citations: 13

  • Assessment of effect of diabetes on health-related quality of life in patients with coronary artery disease using the EQ-5D questionnaire
    B Shah, S Deshpande
    Value in health regional issues 3, 67-72 2014
    Citations: 13

  • Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans?
    M Sharma, J Mohapatra, A Acharya, SS Deshpande, A Chatterjee, ...
    European journal of pharmacology 701 (1-3), 106-113 2013
    Citations: 13

  • Effects of methanolic extract of Holarrhena antidysenterica bark against experimentally induced inflammatory bowel disease in rats
    VC Darji, SS Deshpande, AH Bariya
    Int Res J Pharm 3 (9), 152-4 2012
    Citations: 13

  • A dual action antidepressant
    DS Patel, SS Deshpande, CG Patel, S Singh
    Indo-Glob J Pharml Sci 1 (1), 69 2011
    Citations: 13

  • Anti-inflammatory activity of aqueous extract of Bergenia ciliata rhizomes.
    V Kumar, GB Shah, JR Baheti, SS Deshpande, NS Parmar
     2002
    Citations: 12

  • Efficacy of Myo-inositol on anthropometric, metabolic, and endocrine outcomes in PCOS patients: a meta-analysis of randomized controlled trial
    H Jethaliya, N Gajjar, V Patel, S Deshpande, R Patel
    Reproductive Sciences 29 (8), 2282-2298 2022
    Citations: 11

  • Fructose diet and low dose streptozotocin treatment induces the development of diabetic nephropathy in rats
    R Patel, P Shah, S Deshpande, G Shah, P Gohil
    Oriental Pharmacy and Experimental Medicine 15, 305-312 2015
    Citations: 11

GRANT DETAILS

GUJCOST
AICTE
ICMR
SMMPRC

RESEARCH OUTPUTS (PATENTS, SOFTWARE, PUBLICATIONS, PRODUCTS)

1 patent

CONSULTANCY

GUJPHARM
VIBRANT GUJARAT

INDUSTRY EXPERIENCE

Clinical Research
Regulatory Affairs